Research Institute in Oncology and Hematology

Recent papers from Research Institute in Oncology and Hematology

1. Artificial intelligence–driven prioritization of colonoscopy referrals using multicenter clinical data: addressing imbalanced and incomplete dataInternational Journal of Colorectal Disease · 2026
2. Decompressive craniectomy in adults with moderate to severe traumatic brain injury: A systematic review and meta-analysis of randomised controlled trialsCritical Care and Resuscitation · 2026
3. Evaluating the impact of prevalence on the scaled Brier score, Matthews correlation coefficient, and other performance metrics for binary and multiclass hard classificationsDiscover Data · 2026
4. Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐CPediatric Blood & Cancer · 2026
5. Taste Genetics and Oral Health Symptoms in the Canadian Longitudinal Study on AgingInternational Journal of Molecular Sciences · 2026
6. Liminal Personhood and Continuity of Moral Identity in Clinical CareJournal of Palliative Medicine · 2026
7. Cellular and Immunotherapy for Pediatric Brain Tumors: A PrimerCurrent Oncology · 2026
8. A Novel Poetic Dignity Therapy Adaptation for Sexual and Gender Minority Patients With CancerPsycho-Oncology · 2026
9. Colorectal cancer incidence and mortality by age group, colon location, and histology in CanadaThe American Journal of Gastroenterology · 2026
10. Context-Dependent Modulation of Epithelial Barrier Integrity and Intestinal Permeability by Transcutaneous Auricular Vagus Nerve Stimulation in Two Preclinical Models Mimicking Ulcerative Colitis and Crohn’s Disease: A Descriptive AnalysisInternational Journal of Molecular Sciences · 2026
11. Advances in the management of pediatric low-grade gliomaNeurotherapeutics · 2026
12. Glucagon-like peptide-1 receptor agonists are associated with cardiac, cancer- and mortality-related benefits in diabetic patients treated with anthracyclinesEuropean Heart Journal Open · 2026
13. ID #692 The clinicopathologic characteristics and outcomes of KRAS-altered low-grade gliomaNeuro-Oncology Pediatrics · 2026
14. Bitter taste receptor T2R14 and autophagy inhibition influence programmed cell death proteomic networks in gingival epithelial cellsCell Death · 2026
15. Patient-reported outcomes in BRUIN CLL-321: A randomized phase 3 trial comparing pirtobrutinib to investigators choice of idelalisib plus rituximab or bendamustine plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the post-cBTKi settingJournal of Geriatric Oncology · 2026
16. Connecting Patients with Clinical Trials Using Patient Navigation: A Scoping ReviewCurrent Oncology · 2026
17. Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancersSignal Transduction and Targeted Therapy · 2026
18. Sex-specific risk of mood and anxiety disorders following cancer diagnosis in adolescents and young adults: A Canadian population-based study.Journal of Clinical Oncology · 2026
19. Substance use disorders following cancer diagnosis in adolescents and young adults: A Canadian population-based study.Journal of Clinical Oncology · 2026
20. Extracellular lactate reprograms mitochondrial metabolism and NAD+/NADH redox balance in blood-brain barrier endothelial cells via an LDHB-MPC-NAD+ axisFree Radical Biology and Medicine · 2026